Imatinib alters cell viability but not growth factors levels in TM4 Sertoli cells

BACKGROUND: The anticancer agent imatinib (IM) is a small molecular analog of ATP that inhibits tyrosine kinase activity of platelet derived growth factors (PDGFs) and stem cell factor (SCF) receptor in cancer cells. However these factors have a key role in regulating growth and development of norma...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashemnia, Seyyed Mohammad Reza, Atari-Hajipirloo, Somayeh, Roshan-Milani, Shiva, Valizadeh, Nasim, Mahabadi, Sonya, Kheradmand, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054294/
https://www.ncbi.nlm.nih.gov/pubmed/27738659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054294/
https://www.ncbi.nlm.nih.gov/pubmed/27738659

Ejemplares similares